Skip to main content

Peer Review reports

From: Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data

Original Submission
13 Jan 2024 Submitted Original manuscript
11 Feb 2024 Reviewed Reviewer Report
7 Mar 2024 Reviewed Reviewer Report
8 Mar 2024 Reviewed Reviewer Report
24 Mar 2024 Author responded Author comments - Anja Gäckler
Resubmission - Version 2
24 Mar 2024 Submitted Manuscript version 2
25 Mar 2024 Author responded Author comments - Anja Gäckler
Resubmission - Version 3
25 Mar 2024 Submitted Manuscript version 3
4 Apr 2024 Reviewed Reviewer Report
27 Apr 2024 Author responded Author comments - Anja Gäckler
Resubmission - Version 4
27 Apr 2024 Submitted Manuscript version 4
Publishing
12 Jun 2024 Editorially accepted
19 Jun 2024 Article published 10.1186/s12882-024-03638-3

You can find further information about peer review here.

Back to article page